Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 08, 2022
TriRx Pharmaceutical Services, LLC, a leading international CDMO, announced today that it has finalized and closed on its agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of its manufacturing site in Speke, ...
read more
Tuesday, February 08, 2022
Piramal Pharma Limited's Pharma Solutions business announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure at ...
read more
Friday, February 04, 2022
Medidata, a Dassault Systèmes company, announced that Parexel is extending their 15-year global strategic partnership. This builds upon the trusted relationship between the two companies and sets the goal of jointly pioneering a new era of ...
read more
Friday, February 04, 2022
An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC has formed Pharma Nobis, LLC to acquire Fagron’s US contract manufacturing business. This business unit, operating from a manufacturing facility ...
read more
Friday, February 04, 2022
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-...
read more
Thursday, February 03, 2022
CordenPharma has announced the completion of the acquisition of three manufacturing facilities from Vifor Pharma, to be ultimately renamed Corden Pharma Fribourg S.A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisbon S.A. in ...
read more
Thursday, February 03, 2022
Nashville Biosciences and Datavant announced a collaboration that will enable biopharma companies to connect their trial data to research datasets from BioVU®. The linkages will accelerate drug discovery, clinical development, and drug safety ...
read more
Thursday, February 03, 2022
Fagron has reached an agreement to acquire Letco Medical. The acquisition price is $34 million.
read more
Thursday, February 03, 2022
Worldwide Clinical Trials, Inc. announced its partnership with Ledger Run, Inc. Through this partnership, Worldwide has selected Ledger Run’s unique ClinRun™ platform to streamline and enhance site payment processes with a smart approach that ...
read more
Thursday, February 03, 2022
PCI Pharma Services (PCI) announced the addition of three new automated sterile fill-finish machines in its San Diego and Melbourne facilities. Purchased from Cytiva, this equipment can pivot between filling different sterile medications into vials ...
read more
Thursday, February 03, 2022
Rentschler Biopharma announced that the company has further strengthened its Leadership Team with the hiring of several senior level, highly experienced biopharmaceutical executives.
read more
Wednesday, February 02, 2022
Syner-G BioPharma Group announced the acquisition of Impact Pharmaceutical Services. Based in Research Triangle Park, NC, IMPACT supports the outsourced medical writing, regulatory strategy, and regulatory publishing and submission needs of biotech ...
read more
Wednesday, February 02, 2022
IonsGate Preclinical Services Inc InSilicoTrials have announced a partnership to leverage innovative technology like Modeling and Simulation.
read more
Tuesday, February 01, 2022
Elusys Therapeutics has finalized a contract with the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) for the continued supply of ANTHIM (obiltoxaximab), an anthrax ...
read more
Tuesday, February 01, 2022
Antiverse announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in identifying antibody candidates for a target of interest, with ...
read more